A

Atlas Oncology Partners

Full-risk, value-based oncology care

Network Development Manager

Full-Time
$110k - $150k/yr
Senior
Bachelor's
Remote in USA+1 moreMore locations: Memphis, TN, USA
RemoteTravel at least 50% of the time is required; territory is anticipated to span multiple regions, including the Southeast and Midwest.
Sales & Account ManagementBusiness Development & Partnerships

About the job

Requirements
  • A bachelor's degree.
  • At least 5 years of healthcare experience, including provider growth, partnerships, and/or strategy.
  • Ability to organize a sales enablement portfolio, including tools, processes, and development activities, to ensure the in-market team is differentiated through knowledge and proficiency.
  • Ability to collaborate with internal teams to manage existing provider accounts through implementation with strong performance and retention.
  • Ability to travel at least 50% of the time.
  • Comfort with change, process improvement, and working in a start-up or high-growth organization.
  • Proficiency with HubSpot or comparable customer relationship management systems for pipeline management and reporting.
  • Proficiency in Microsoft Excel, PowerPoint, Outlook, and Teams.
Responsibilities
  • Own the provider partner business development process end-to-end for the territory, from sourcing and qualification through diligence, negotiations, and contracting, for deals ranging from hundreds of thousands to multiple millions of dollars in contract value.
  • Build and lead long-term relationships with physician partners in the designated region or area, driving execution of Atlas’ growth strategy.
  • Lead cross-functional collaboration with product, operations, and clinical teams to align solutions with provider needs.
  • Track industry trends and competitive dynamics to shape and sharpen pursuit strategy.
  • Drive refinement of the growth strategy in partnership with the Senior Director of Provider Growth and members of the executive team, as needed.
  • Source leads, qualify prospective partners, develop supporting materials, support collaborative diligence, meet prospective physician partners, assist with negotiating contracts with physician practices, and serve as a long-term contact to providers during and after implementation of the Atlas Care Model.
  • Provide feedback to clinical and operations teams to help incorporate feature improvements in clinical and engagement models that better respond to physician partners’ needs and desires.
Desired Qualifications
  • Experience communicating with healthcare providers and practice administrators.
  • A proven track record of accomplishment in complex provider business development.
  • A strong retention record and track record of keeping and honing mutually beneficial partnerships.
  • Deep understanding of value-based care programs, such as STARS and RAF, and provider friction points with payers, such as utilization management and treatment selection autonomy.
  • Ability to proactively manage a pipeline with attention to detail and organization.

About the company

A

Atlas Oncology Partners

View

Atlas Oncology Partners embeds an interdisciplinary Extended Care Team into community oncology practices and assumes full medical cost risk with payers under outcomes-based contracts. The Extended Care Team—physicians, nurses, patient navigators, and social workers—delivers wrap-around services, including proactive care coordination, 24/7 symptom triage, management of cancer-adjacent conditions, psychosocial support, and supportive care, with same- or next-day access to care to reduce ER visits. The platform unifies multiple data sources to provide actionable insights for providers and staff, and Atlas funds infrastructure, technology, and staff for partner practices to align incentives with high-value care. The company plans to expand across the Southeast (Alabama, Arkansas, Louisiana, Texas) with a goal of improving patient outcomes and experiences while lowering total cancer care costs.

Company Size

11-50

Company Stage

Series A

Total Funding

$28M

Headquarters

Nashville, Tennessee

Founded

2025

Get referred to Atlas Oncology Partners

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Atlas hired Robert Sepucha as CEO on September 1, 2026, signaling scaling discipline.
  • Atlas now partners across three states and targets four markets by year-end 2026.
  • Rubicon and Flare promised up to $100 million more capital, funding Southeast expansion.

What critics are saying

  • Atlas depends on Humana Medicare Advantage volume in Tennessee and Mississippi through 2026.
  • Full medical-cost risk makes one bad claims year threaten Atlas's entire balance sheet.
  • One partner, West Cancer Center, limits density; provider defections can break expansion plans.

What makes Atlas Oncology Partners unique

  • Rubicon Founders incubated Atlas; Flare Capital led its $28M Series A on February 11, 2026.
  • Atlas embeds local interdisciplinary care teams inside community oncology practices, not centralized virtual call centers.
  • Humana launched Atlas coverage January 1, 2026, validating payer demand for full-risk oncology contracts.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Vacation
  • Paid Holidays
  • Paid Sick Leave

Growth & Insights and Company News

Headcount

6 month growth

6%

1 year growth

6%

2 year growth

6%
The Pharma Data
Feb 12th, 2026
Atlas Oncology Partners Secures $28M Series A Funding to Expand Value-Based Cancer Care

Atlas Oncology Partners secures $28M Series A funding to expand value-based cancer care. Atlas Oncology Partners raises $28M Series A to scale value-based oncology care. * Atlas Oncology Partners is a value-based oncology enablement platform that embeds interdisciplinary care teams into community oncology practices and assumes full medical cost risk to improve patient outcomes and experience. Atlas Oncology Partners today announced the closing of its Series A financing. Atlas was founded by Rubicon Founders, a healthcare investment firm focused on building and growing companies that transform the way people receive care. The financing round was led by Flare Capital Partners with significant participation from Rubicon Founders. The $28 million funding round will be used to expand Atlas' geographic footprint with more oncology practice partners and invest in clinical and operational infrastructure. Cancer care is often fragmented, forcing patients to navigate multiple providers while managing complex clinical and social needs. Atlas was founded to address these challenges by embedding interdisciplinary care teams - providers, nurses, patient navigators, and social workers - directly into oncology practices, enabling coordinated, patient-centered care during and beyond active treatment. "From the moment of diagnosis, patients can feel overwhelmed by the complexity of cancer care," said Kate Barnard Roberts, President and Co-Founder of Atlas Oncology Partners. "Atlas was built to simplify that experience by embedding holistic, coordinated support into oncology practices. This investment enables us to scale our model and reach more patients while staying true to our mission of improving quality of life and outcomes." Atlas' model combines patient navigation, psychosocial and supportive care, proactive care coordination, and expanded in-person and virtual clinical access. Atlas assumes full medical cost risk from payors and aligns incentives with a high-value network of medical oncology practice partners. To succeed in these arrangements, Atlas makes investments to support partner operations, leading to high-quality, value-based care that reduces avoidable costs and eases the financial burden on patients. "We incubated and invested in Atlas Oncology Partners to fundamentally rethink how cancer care is delivered," said Matt Kim, Partner at Rubicon Founders. "By embedding interdisciplinary teams directly into oncology practices and assuming full medical cost risk, Atlas is building a scalable model that improves outcomes, experience, and affordability." "Atlas Oncology Partners is addressing one of the most complex and costly areas of healthcare with a model that is deeply aligned with patients, oncologists, and payers at the forefront of value-based care," said Ian Chiang, Partner at Flare Capital Partners. "We are excited to lead their Series A and support Atlas as it scales the next-generation value-based oncology model - one that empowers community oncology groups to deliver coordinated, holistic care at scale and drives impactful clinical outcomes for patients and families impacted by cancer." About Atlas Oncology Partners Atlas Oncology Partners is dedicated to delivering uplifting and responsive cancer care during and beyond treatment. By partnering with leading oncologists and taking full medical cost risk, Atlas offers an innovative solution that delivers better care experiences while easing the economic strain of cancer treatment. About Rubicon Founders Rubicon Founders is an entrepreneurial healthcare investment firm focused on building and growing transformational companies that create enduring value by transforming the way people receive care. Rubicon Founders brings together a core team of investment, operating, and technology professionals who work to put patients and doctors first. About Flare Capital Partners Flare Capital Partners is the leading healthcare technology venture capital firm advancing innovation-driven companies to improve positive health outcomes, broaden care access, and lower healthcare costs. We partner with exceptional founders solving healthcare's hardest challenges, supporting each with our deep sector expertise, unparalleled industry resources, and proven access to commercial opportunities. Our team of established investors and senior operating executives has invested in 70+ companies and has nearly $1 billion in assets under management.

FinSMEs
Feb 11th, 2026
Atlas Oncology Partners Raises $28M in Series A Funding

Atlas Oncology Partners, a Nashville, TN-based provider of a value-based oncology enablement platform, raised $28M in Series A funding